PEPNS System Feasibility Study

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-10

Study Completion Date

2019-05-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this feasibility study is to evaluate the safety and performance of the PEPNS System in patients that need to be mechanically ventilated for at least 48 hours and up to 7 days in the Intensive Care Unit (ICU).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Implanted Phrenic Nerve Stimulator Database.

NCT03659019

External Mechanical Ventilatory Support

RECRUITING

Mapping for Acute Transvenous Phrenic Nerve Stimulation Study

NCT01981590

Sleep Apnea

COMPLETED NA

Effects of Transcutaneous Electrical Phrenic Nerve Stimulation and Transcutaneous Electrical Diaphragmatic Stimulation

NCT06339632

Diaphragm

RECRUITING NA

Proof-of-Concept Study Assessing VNS Paired With Tones for Tinnitus

NCT01253616

Severe Tinnitus

COMPLETED NA

Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS)

NCT03179202

Back Pain Low Back Pain

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mechanical ventilation is a life saving technology but can also cause damage to the lungs and diaphragm such as ventilator induced diaphragmatic dysfunction (VIDD). Research has shown that after being on mandatory mechanical ventilation and sedation the diaphragm begins to atrophy within as little as 18 hours. The PEPNS System consists of a console and disposable lead and will be used to stimulate the patient's diaphragm to contract in synchrony with the inspiratory cycle of the ventilator. The proprietary phrenic nerve to diaphragm stimulation (pdSTIM) Lead incorporates multipolar electrodes that align with the left and right phrenic nerves in order to stimulate the nerves to the diaphragm. This feasibility trial will investigate the safety and performance of the PEPNS System as a therapy by stimulating the diaphragm over a 48 hour period to facilitate weaning from the mechanical ventilator. The patient population includes those need to be mechanically ventilated for at least 48 hours and up to 7 days in the ICU.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventilator Induced Diaphragmatic Dysfunction (VIDD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

The pdSTIM Leads are temporarily inserted near the right and left phrenic nerves and connected to the PEPNS System console. Duration of stimulation in PEPNS study is up to 48 hours to allow periodic electrical stimulation in daily sessions until the patients is weaned or 48 hours since initiation of stimulation session has elapsed.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PEPNS System

The pdSTIM lead will be temporarily inserted near the right and left phrenic nerves and connected to the PEPNS system console in order to stimulate the phrenic nerves and activate the diaphragm on the patients until extubated/removed from mechanical ventilation or until 48 hours has elapsed, whichever comes first.

Group Type EXPERIMENTAL

PEPNS System

Intervention Type DEVICE

PEPNS System therapy will be delivered periodically up to 48 hours or less if patient is no longer being mechanically ventilated.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PEPNS System

PEPNS System therapy will be delivered periodically up to 48 hours or less if patient is no longer being mechanically ventilated.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

pdSTIM

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 18 years or older (Adult).
2. Able and willing to give informed consent or whose legally authorized representative is able and willing to give informed consent.
3. Subject who in the opinion of the admitting consultant/intensivist is likely to be ventilated for \> 48 hours from time of recruitment since study treatment will be for up to 48 hours.

Exclusion Criteria

1. Subject has a left ventricular ejection fraction (LVEF) \< 20%.
2. Subject unlikely to survive 72 hours due to coexisting medical conditions.
3. Subject has an implanted pulse generator or implanted electronic device:
4. Subject has experienced an Acute Myocardial Infarction (AMI) within 72 hours prior to this screening or patient is on high dose inotropic support or subject is deemed to be in cardiogenic shock.
5. Subject has significant bleeding diathesis, or is at risk of significant haemorrhage, patient is receiving full dose systemic anticoagulation
6. Subject has a known or suspected phrenic nerve paralysis or neuromuscular or inflammatory muscle diseases where the diaphragm itself may not be functional.
7. Subject has an active systemic infection or local infection at or around the insertion site. Subject is neutropenic or has signs of significant immunocompromise.
8. Subject is known or suspected to be pregnant or is lactating.
9. Subject will be unavailable for, or is unwilling to comply with, follow up requirements of the protocol.
10. Subject is currently enrolled or is expected to be enrolled in any other study of an investigational drug or device who has received treatment under that protocol with the investigational product during the 30 days prior to screening.
11. Subject has undergone a surgery or interventional procedure within the neck region aside from placement of an internal jugular (IJ) vein catheter.
12. Subject has been diagnosed and has been treated for neck cancer within the past 5 years.
13. Subject is known to have a demonstrated intra cardiac thrombus on echocardiography.
14. Subject has uncontrolled hyperthyroidism, hypertension.
15. Subject has had any cerebral ischemic event (Stroke or Transient Ischemic Attack TIA) in the 6-month interval preceding the screening date.
16. Subject has degenerative nerve disorders such as amyotrophic laterals sclerosis (ALS).
17. Subject has an elevated hemidiaphragm on chest x-ray.
18. Subject written informed consent not obtained.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No